Parallax Volatility Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-116,400
Closed -$1.29M 2715
2023
Q2
$1.29M Buy
+116,400
New +$1.62M ﹤0.01% 1306
2023
Q1
Sell
-10,000
Closed -$124K 3320
2022
Q4
$124K Sell
10,000
-23,000
-70% -$326K ﹤0.01% 2229
2022
Q3
$461K Buy
+33,000
New +$531K ﹤0.01% 2002
2022
Q1
Sell
-183,400
Closed -$2.99M 3339
2021
Q4
$2.99M Hold
183,400
﹤0.01% 951
2021
Q3
$2.72M Buy
+183,400
New +$2.93M ﹤0.01% 1039
2021
Q1
Sell
-212,600
Closed -$5.25M 2249
2020
Q4
$5.25M Buy
212,600
+300
+0.1% +$9.94K 0.01% 936
2020
Q3
$8.8M Buy
212,300
+1,300
+0.6% +$59.7K 0.01% 1057
2020
Q2
$10.1M Buy
211,000
+48,400
+30% +$3.74M 0.01% 778
2020
Q1
$10.2M Buy
162,600
+152,600
+1,526% +$13.7M 0.01% 601
2019
Q4
$1.24M Hold
10,000
﹤0.01% 1435
2019
Q3
$664K Hold
10,000
﹤0.01% 1528
2019
Q2
$796K Buy
10,000
+6,000
+150% +$537K ﹤0.01% 1352
2019
Q1
$447K Hold
4,000
﹤0.01% 1584
2018
Q4
$403K Hold
4,000
﹤0.01% 1565
2018
Q3
$505K Buy
+4,000
New +$423K ﹤0.01% 1431
2017
Q4
Sell
-10,000
Closed -$580K 5137
2017
Q3
$580K Buy
+10,000
New +$1.08M ﹤0.01% 1212
2016
Q1
Sell
-25,000
Closed -$3.73M 3939
2015
Q4
$3.73M Buy
+25,000
New +$4.23M 0.01% 789

Other funds holding ICPT

Parallax Volatility Advisers's ICPT Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 275 shares — an estimated $3.83K sold.

Parallax Volatility Advisers first reported a position in ICPT in Q4 2015 and held it in 17 quarters. The position peaked at $2.04M in Q4 2021. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

  • Parallax Volatility Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 275 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.83K.
  • Parallax Volatility Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 17 quarters.
  • Parallax Volatility Advisers's Intercept Pharmaceuticals, Inc. position peaked at $2.04M in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.